EU HEALTH CLAIMS · COURT DECISION · CHECKED 23 SEPTEMBER 2026
Can dosage instructions become a health claim?
Yes. In Vista-Life Pharma, C-721/24, the Court held that frequency or method of administration can be a health claim when the way of taking a supplement is presented as linked to a health benefit or to avoiding an adverse effect.
The link to a health effect is the deciding feature.
“Take one capsule daily” is a practical instruction by itself. “Daily is better than one large dose” or “sublingual use improves absorption” suggests a benefit from the administration method and needs health-claim review. The Court did not create a blanket rule that every dosage instruction is a claim.
Administration can imply a product–health relationship.
The dispute included “daily better than single dose” and a sublingual route said to provide faster absorption and avoid degradation. The Court read “claim” broadly enough to include a manner of consumption presented as relevant to the product’s characteristics. The health-claim test then asks whether the communication states, suggests or implies a link with health. See paragraphs 45–57 and operative part 1.
No benefit from the frequency is asserted in this sentence alone. The surrounding presentation still matters.
The frequency is linked to an implied physiological effect. Review the complete message and applicable authorisation.
Scan the relationship, then the claim package.
Claim Context Engine v2 tags frequency, route and timing together with absorption, bioavailability, stability and avoidance language. A matched sentence receives “Potential health claim inferred from administration wording”. It then needs the relevant authorised claim, conditions of use, operator entitlement, product facts and full presentation checked. This deterministic preview cannot infer every implied meaning.
A detected signal is not a legality verdict.
The judgment interprets the definition of a health claim; it does not authorise any particular frequency or route wording. A phrase that the scanner does not match may still imply a health effect in context. Human review remains necessary for commercial copy.
Check the sentence before publishing it.
Paste an administration instruction and inspect the detected relationship and primary source.
Judgment and original language.
Vista-Life Pharma, C-721/24 · French original17 September 2026 · ECLI:EU:C:2026:775 ↗Vista-Life Pharma, C-721/24 · English reference textParagraphs 45–57 and operative part 1 ↗Point-in-time source check on 23 September 2026. The original French judgment controls; the English text is used for this working explanation. Educational analysis, not product approval or legal advice. See also where mandatory information belongs in written advertising.